Literature DB >> 11860168

Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia.

F Nayeri1, E Millinger, I Nilsson, L Brudin, P Forsberg.   

Abstract

Hepatocyte growth factor (HGF) is a protein produced by mesenchymal cells in many organs, which can stimulate epithelial growth. An enhanced production and concentration of HGF is observed after injuries. The lung is one of the major sources of HGF. By cooling exhaled air, a condensate is formed containing molecules from bronchi and alveoli. In order to investigate HGF-concentration and time course in pneumonia, paired serum and exhaled breath condensate was collected from 10 patients with pneumonia, 10 patients with non-respiratory infections and 11 healthy controls. The concentration of HGF was measured by an immunoassay kit. In the acute phase HGF-levels in breath condensate and serum were significantly higher in the patients with pneumonia compared to the control groups. Similar concentrations in breath condensate were seen in healthy controls and in patients with non-respiratory infections. In the patients with pneumonia a decrease in serum HGF was seen already after 4-7 days while HGF values in breath condensate remained elevated even after 4-6 weeks. These results might imply local product on of HGF in the lungs and a long repair and healing process after pneumonia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11860168     DOI: 10.1053/rmed.2001.1225

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

Review 1.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

2.  Hepatocyte growth factor levels in Legionella pneumonia: a retrospective study.

Authors:  Futoshi Higa; Morikazu Akamine; Makoto Furugen; Kenji Hibiya; Michio Koide; Maki Tamayose; Yuichiro Tamaki; Syusaku Haranaga; Noriko Arakaki; Satomi Yara; Masao Tateyama; Jiro Fujita
Journal:  BMC Infect Dis       Date:  2011-03-23       Impact factor: 3.090

3.  Hepatocyte growth factor (HGF) in fecal samples: rapid detection by surface plasmon resonance.

Authors:  Fariba Nayeri; Daniel Aili; Tayeb Nayeri; Junyang Xu; Sven Almer; Ingemar Lundström; Britt Akerlind; Bo Liedberg
Journal:  BMC Gastroenterol       Date:  2005-04-12       Impact factor: 3.067

4.  Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosis.

Authors:  Amir Ramezani; Katarina Nägga; Oskar Hansson; Johanna Lönn; Johanna Sjöwall; Fateme Katoozian; Sepahdar Mansouri; Fariba Nayeri
Journal:  Fluids Barriers CNS       Date:  2015-09-25

5.  Clinical impact of real-time evaluation of the biological activity and degradation of hepatocyte growth factor.

Authors:  Fariba Nayeri; Tayeb Nayeri; Daniel Aili; Lars Brudin; Bo Liedberg
Journal:  Growth Factors       Date:  2008-06       Impact factor: 2.511

6.  One-minute through test to distinguish lower respiratory infection by analysis of sputum; exploring the mechanisms.

Authors:  Amir Ramezani; Mahin Alipouratigh; Lars Eng; Maria V Turkina; Johanna Lönn; Annette Theodorsson; Fariba Nayeri
Journal:  BMC Res Notes       Date:  2018-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.